Brief: Enorama Pharma Q4 Operating Loss Widens To SEK 6.1 Million
Feb 21 (Reuters) - Enorama Pharma AB ERMA.ST :
* Q4 OPERATING LOSS SEK 6.1 MILLION VERSUS LOSS SEK 2.4
MILLION
YEAR AGO
* Q4 NET SALES SEK 1.1 MILLION VERSUS SEK 1.6 MILLION YEAR
AGO
Source text for Eikon: ID:nWkr90LW6Q
Further company coverage: ERMA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO